Build with KISHO Sign In Sign Up

Kisho

Novartis Pharmaceutical Corporation — Rare Disease Pipeline | Kisho | Kisho

Novartis Pharmaceutical Corporation

Other

8

Orphan Designations

0

FDA Approvals

14

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
B-cell chronic lymphocytic leukemia	Recombinant anti-CD40 monoclonal antibody	Orphan Designation	-
autoimmune lymphoproliferative syndrome	secukinumab	Orphan Designation	-
autoimmune thrombocytopenic purpura	Ianalumab	Orphan Designation	-
chronic inflammatory demyelinating polyradiculoneuropathy	fingolimod	Orphan Designation	-
inborn error of immunity	Ianalumab	Orphan Designation	-
lepromatous leprosy	Lamprene	Orphan Designation	-
micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome	secukinumab	Orphan Designation	-
nephrotic syndrome 14	Ianalumab	Orphan Designation	-
non-immunoglobulin-mediated membranoproliferative glomerulonephritis	secukinumab	Orphan Designation	-
ovarian cancer	Patupilone	Orphan Designation	-
plasma cell myeloma	Recombinant anti-CD-40 monoclonal antibody	Orphan Designation	-
symptomatic form of Coffin-Lowry syndrome in female carriers	Cibacalcin	Orphan Designation	-
symptomatic form of fragile X syndrome in female carrier	Cibacalcin	Orphan Designation	-
symptomatic form of hemophilia A in female carriers	Cibacalcin	Orphan Designation	-

← Back to Companies